Elenco degli articoli con argomento «alopecia areata»

Dermatologia

10 feb 2025

Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata

ALLEGRO-LT is an ongoing, long-term

04 dic 2024

Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata

Ritlecitinib and baricitinib are recently approved systemic treatments for severe alopecia areata (AA)

04 dic 2024

Approved systemic drugs needed for dermatosis like alopecia areata

Approved systemic drugs needed for dermatosis

29 nov 2024

Sesta giornata italiana Alopecia Areata navigation-next-alternate

L’alopecia areata nei 5 steps da conoscere

24 ott 2024

Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata

Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp

19 ott 2024

SIDeMaST Talk - Puntata 5 navigation-next-alternate

Parliamo di Papilloma Virus e PrEP con il Dr. Luigi Pisano

22 lug 2024

Innovazione terapeutica in tricologia: Jak-inibitori e alopecia areata navigation-next-alternate

Alopecia areata è una patologia autoimmune del follicolo pilifero di capelli e peli di tutto il corpo

25 giu 2024

Italian National Registry of Alopecia Areata

Alopecia areata (AA) is an organ-specific autoimmune disease that affects the hair follicles

24 mag 2024

Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata

Alopecia areata (AA) is an autoimmune disorder that affects the hair follicles, resulting in patchy recurrent hair loss

25 mar 2024

Alopecia areata: Line-field confocal optical coherence tomography

Alopecia areata: Line-field confocal optical coherence tomography

25 mar 2024

Long-term efficacy and safety of baricitinib in patients with severe alopecia areata

Efficacy of the Janus kinase (JAK) inhibitor baricitinib for severe alopecia areata (AA)

16 gen 2024

Questionario di laboratorio nell'alopecia areata

Questa indagine mira a valutare la pratica dei dermatologi riguardo all'uso di test di laboratorio nell'alopecia areata. I risultati saranno utilizzati per informare la pratica clinica e le linee guida.

19 dic 2023

Effect of baricitinib in patients with alopecia areata

Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation

24 nov 2023

Un aggiornamento per te da EADV 2023 navigation-next-alternate

Inibitori di JAK nelle indicazioni dermatologiche

23 nov 2023

When to expect scalp hair regrowth during treatment of severe alopecia areata

Baricitinib is approved for the treatment of adults with severe alopecia areata (AA)

31 ott 2023

Induced hair loss

This article discusses drug-induced hair loss

13 giu 2023

Impact and Management of Loss of Eyebrows

Eyelashes and eyebrows have different functions, ranging from practical purposes such as protecting the eye apparatus from external hazards

20 feb 2023

A Review on the Safety of Using JAK Inhibitors in Dermatology

Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions

03 feb 2023

Survey Alopecia Areata navigation-next-alternate

Studio per valutare l'approccio diagnostico e terapeutico nei pazienti affetti da Alopecia Areata

23 gen 2023

Systematic review of newer agents for the management of alopecia areata

Management options for moderate-to-severe alopecia areata (AA) are limited owing to a lack of safe and effective treatments suitable for long-term use